Familial breast cancer (update): guideline consultation
This updated guideline is in draft form for consultation. It includes
a number of potential new recommendations on issues including; when to
offer genetic testing; what surveillance strategies should and should
not be offered; and the use of tamoxifen or raloxifene as treatments to
prevent breast cancer. Registered stakeholders are invited to comment on
the provisional recommendations until the 25th February 2013.
Press release
Consultation documents and further information
Source: Health Management Specialist Library - Category: UK Health Authors: The King's Fund Information & Library Service Source Type: blogs
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Evista | Genetics | Health | Tamoxifen | UK Health